The Role of Stem Cells as Therapeutics for Ischaemic Stroke
Cells · 06.01.2024 · 13 (2) · 112
DOI: 10.3390/cells13020112 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 06.01.2024. Verfasst von Jingyuan Ya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit of Mental Health and Clinical Neurosciences, Queens Medical Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, U…. Hauptthemen laut MEDLINE: Stroke, Brain Ischemia, Ischemic Stroke, Neural Stem Cells. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Stroke remains one of the leading causes of death and disability worldwide. Current reperfusion treatments for ischaemic stroke are limited due to their narrow therapeutic window in rescuing ischaemic penumbra. Stem cell therapy offers a promising alternative. As a regenerative medicine, stem cells offer a wider range of treatment strategies, including long-term intervention for chronic patients, through the reparation and replacement of injured cells via mechanisms of differentiation and proliferation. The purpose of this review is to evaluate the therapeutic role of stem cells for ischaemic stroke. This paper discusses the pathology during acute, subacute, and chronic phases of cerebral ischaemic injury, highlights the mechanisms involved in mesenchymal, endothelial, haematopoietic, and neural stem cell-mediated cerebrovascular regeneration, and evaluates the pre-clinical and clinical data concerning the safety and efficacy of stem cell-based treatments. The treatment of stroke patients with different types of stem cells appears to be safe and efficacious even at relatively higher concentrations irrespective of the route and timing of administration. The priming or pre-conditioning of cells prior to administration appears to help augment their therapeutic impact. However, larger patient cohorts and later-phase trials are required to consolidate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academic Unit of Mental Health and Clinical Neurosciences, Queens Medical Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
ORCID-Profile: Jingyuan Ya
Zitieren
APA
Ya, J., Pellumbaj, J., Hashmat, A., & Bayraktutan, U. (2024). The Role of Stem Cells as Therapeutics for Ischaemic Stroke. Cells, 13(2), 112. https://doi.org/10.3390/cells13020112
Vancouver
Ya J, Pellumbaj J, Hashmat A, Bayraktutan U. The Role of Stem Cells as Therapeutics for Ischaemic Stroke. Cells. 2024;13(2):112. doi:10.3390/cells13020112
BibTeX
@article{Ya2024,
author = {Ya, Jingyuan and Pellumbaj, Jessica and Hashmat, Arshad and Bayraktutan, Ulvi},
title = {The Role of Stem Cells as Therapeutics for Ischaemic Stroke},
journal = {Cells},
year = {2024},
volume = {13},
number = {2},
pages = {112},
doi = {10.3390/cells13020112}
}
EUVIMED